{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:50:39Z","timestamp":1760161839557,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Plasma fibroblast skin tightening treatment is a relatively novel and growing minimally invasive aesthetic skin procedure. The treatment claims to rejuvenate skin by improving facial lines, wrinkles and skin pigmentation associated with photo-ageing. The skin is often anaesthetised prior to the procedure with topical creams such as EMLA (Eutectic mixture of local anaesthetics). We present the first case of bilateral chemical eye injury following plasma fibroblast skin tightening treatment secondary to EMLA cream. EMLA cream was inadvertently administered to both eyes in preparation for the treatment.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A patient was referred from the emergency department to a tertiary ophthalmology centre with bilateral exquisite eye pain, inability to open the eyes, photosensitivity and reduced vision. She underwent cosmetic plasma fibroblast skin tightening treatment at her local salon four hours earlier. She was found to have bilateral alkali chemical eye injuries with significant diffuse corneal epithelial loss. The injury was thought to be caused by inadvertent ocular exposure to EMLA cream, which was used in preparation for the plasma fibroblast skin tightening treatment. She was treated with topical antibiotics and achieved satisfactory recovery.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This case report highlights a possible complication following plasma fibroblast skin tightening treatment. We lay emphasis on the importance identifying chemical injury and recommend that medication attention should be sought if there is any concern.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12886-020-01613-8","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T12:03:37Z","timestamp":1598270617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Plasma fibroblast skin tightening treatment resulting in bilateral chemical eye injury secondary to EMLA cream: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4991-0737","authenticated-orcid":false,"given":"Sirjhun","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohith","family":"Shamdas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"key":"1613_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1473-2165.2008.00411.x","volume":"7","author":"ML Elsaie","year":"2008","unstructured":"Elsaie ML, Kammer JN. Evaluation of plasma skin regeneration technology for cutaneous remodeling. J Cosmet Dermatol. 2008;7:309\u201311.","journal-title":"J Cosmet Dermatol"},{"key":"1613_CR2","first-page":"231","volume":"7","author":"MM Loesch","year":"2014","unstructured":"Loesch MM, Somani A-K, Kingsley MM, et al. Skin resurfacing procedures: new and emerging options. Clin Cosmet Investig Dermatol. 2014;7:231\u201341.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1613_CR3","first-page":"7","volume":"11","author":"MA Bogle","year":"2006","unstructured":"Bogle MA. Plasma skin regeneration technology. Skin Therapy Lett. 2006;11:7\u20139.","journal-title":"Skin Therapy Lett"},{"key":"1613_CR4","unstructured":"Medicines.org.uk (2019) EMLA Cream 5%(for 5 g and pre-medication packs) Summary of Product Characteristics (SmPC) \u2013 (eMC). [online] https:\/\/www.medicines.org.uk\/emc\/product\/871\/smpc [Accessed on 06\/07\/2019]."},{"issue":"2","key":"1613_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/0974-620X.116624","volume":"6","author":"P Singh","year":"2013","unstructured":"Singh P, Tyagi M, Kumar Y, Gupta KK, Sharma PD. Ocular chemical injuries and their management. Oman J Ophthalmol. 2013;6(2):83\u20136.","journal-title":"Oman J Ophthalmol"},{"issue":"7","key":"1613_CR6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1046\/j.1524-4725.1999.98289.x","volume":"25","author":"F Eaglstein","year":"1999","unstructured":"Eaglstein F. Chemical injury to the eye from EMLA cream during erbium laser resurfacing. Dermatol Surg. 1999;25(7):590\u20131.","journal-title":"Dermatol Surg"},{"key":"1613_CR7","doi-asserted-by":"crossref","unstructured":"Shin JH, Chung JK. A Case of Keratoconjunctival Chemical Injury from a Topical Anesthetic Ointment J Korean Ophthalmol Soc 2012;53(7):1030\u20131034.","DOI":"10.3341\/jkos.2012.53.7.1030"},{"issue":"5","key":"1613_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/eye.1995.164","volume":"9","author":"AK Brahma","year":"1995","unstructured":"Brahma AK, Inkster C. Alkaline chemical ocular injury from Emla cream. Eye. 1995;9(5):658\u20139.","journal-title":"Eye"},{"key":"1613_CR9","doi-asserted-by":"crossref","unstructured":"Joseph R. McKinlay; Elizabeth Hofmeister; E Victor Ross; et al. Waine MacAllister EMLA Cream\u2013Induced Eye Injury Arch Dermatol 1999;135(7):855\u2013856.","DOI":"10.1001\/archderm.135.7.855"},{"issue":"1","key":"1613_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijpharm.2017.09.070","volume":"533","author":"GL See","year":"2017","unstructured":"See GL, Sagesaka A, Sugasawa S, Todo H, Sugibayashi K. Eyelid skin as a potential site for drug delivery to conjunctiva and ocular tissues. Int J Pharm. 2017;533(1):198\u2013205.","journal-title":"Int J Pharm"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-020-01613-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T23:36:36Z","timestamp":1629761796000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01613-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1613"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01613-8","relation":{},"ISSN":["1471-2415"],"issn-type":[{"type":"electronic","value":"1471-2415"}],"subject":[],"published":{"date-parts":[[2020,8,24]]},"assertion":[{"value":"17 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Full written consent has been obtained from the patient. The patient has approved the figures used and is aware that some features may be identifiable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"342"}}